Skip to content

Homeopathic Approach To Prostate Enlargment Role Of Boerickes Repertory

Evaluating the Clinical Relevance of Rubrics for Benign Prostatic Hyperplasia in Boericke s Repertory - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109806
Enrollment
60
Registered
2026-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms

Interventions

Intervention1: Individualized Homoeopathic Treatment using Boerickes Repertory: Patients diagnosed with benign prostatic hyperplasia will receive individualized homoeopathic medicines selected based o

Sponsors

Janak Limbachiya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Dignosed Case Of Bph

Exclusion criteria

Exclusion criteria: Case Which Need Emergency Treatment Cases with PSA Level Above 10Ng/Ml

Design outcomes

Primary

MeasureTime frame
Change In International Prostate Symptom Score Ipss From Baseline To End TreatmentTimepoint: Change in International Prostate Symptom Score (IPSS) will be assessed at baseline, 4 weeks, 8 weeks, and 12 weeks

Secondary

MeasureTime frame
Improvement in quality of life associated with urinary symptomsTimepoint: Baseline, 4 weeks, 8 weeks, 12 weeks;Reduction in frequency of nocturiaTimepoint: Baseline, 4 weeks, 8 weeks, 12 weeks;Improvement in urinary symptoms such as frequency, urgency, hesitancy, & weak streamTimepoint: Baseline, 4 weeks, 8 weeks, 12 weeks;Overall clinical improvement assessed by percentage change in IPSS score categories (mild/ moderate/severe)Timepoint: At 12 weeks

Countries

India

Contacts

Public ContactDr Prajali Shrirame

Shree Swaminarayan Homoeopathic College

shrirameprajali@gmail.com9833233472

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026